Several studies demonstrated that besides reduced glucose uptake, insulin resistance and hyperglycemic conditions also alter cellular lipid metabolism, leading to the development of dyslipidemia in mammals (Schofield et al., 2016). This evidence concerns the gene INS and metabolic syndrome.